⌘K
t
GlaxoSmithKline plc submitted a Block Listing Six Monthly Return on 15 November 2021 for the period from 1 May 2021 to 31 October 2021. For the 2017 Deferred Annual Bonus Plan, 0 securities were issued during the period, and the block listing increased by 230,000, leaving 265,519 unallotted securities. Under the Share Save Plan 2012, 313,319 securities were issued, and the block listing increased by 3,000,000, with 3,069,147 unallotted securities remaining.
| Date | 15 Nov 2021 |
| Time | 16:37:51 |
| Category | Capital structure |
| ID | 4366S |
BLOCK LISTING SIX MONTHLY RETURN
Date: 15 November 2021
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan |
|||
|
Period of return: |
From: |
1 May 2021 |
To: |
31 October 2021 |
|
Balance of unallotted securities under scheme(s) from previous return: |
35,519 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
230,000 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
265,519 |
|||
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline plc Share Save Plan 2012 |
|||
|
Period of return: |
From: |
1 May 2021 |
To: |
31 October 2021 |
|
Balance of unallotted securities under scheme(s) from previous return: |
382,466 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
3,000,000 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
313,319 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
3,069,147 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |